The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized phase II study of personalized peptide vaccination in patients with advanced bladder cancer progressing after chemotherapy.
Masanori Noguchi
No relevant relationships to disclose
Kazumasa Matsumoto
No relevant relationships to disclose
Hirotsugu Uemura
No relevant relationships to disclose
Gaku Arai
No relevant relationships to disclose
Masatoshi Eto
No relevant relationships to disclose
Seiji Naito
No relevant relationships to disclose
Chikara Ohyama
No relevant relationships to disclose
Yasutomo Nasu
No relevant relationships to disclose
Masatoshi Tanaka
No relevant relationships to disclose
Fukuko Moriya
No relevant relationships to disclose
Shigetaka Suekane
No relevant relationships to disclose
Satoko Matsueda
No relevant relationships to disclose
Nobukazu Komatsu
No relevant relationships to disclose
Tetsuro Sasada
No relevant relationships to disclose
Akira Yamada
No relevant relationships to disclose
Kyogo Itoh
No relevant relationships to disclose